Target intelligence / Profile preview

Glucosyltransferase B (GtfB) and Glucosyltransferase C (GtfC) of Streptococcus mutans (GtfB and GtfC)

Target
GtfB and GtfC
Molecular classification
Enzyme, Glycosyltransferase, Glucansucrase
01

Overview

Glucosyltransferase B (GtfB) and Glucosyltransferase C (GtfC) are key extracellular enzymes produced by the bacterium Streptococcus mutans, the primary etiological agent of dental caries. These enzymes utilize dietary sucrose to synthesize glucan polymers, which form the structural scaffold of the dental biofilm (plaque). GtfB primarily synthesizes water-insoluble glucans (alpha-1,3-linkages) that promote bacterial aggregation and cohesion, while GtfC produces a mixture of soluble and insoluble glucans and is critical for initial adherence to the tooth surface. Because these enzymes are essential for the formation of cariogenic biofilms but are not required for bacterial survival, they are considered ideal targets for anti-virulence therapies that aim to prevent tooth decay without exerting the selective pressure of traditional antibiotics. Various natural polyphenols and synthetic small molecules have been identified as inhibitors that can disrupt biofilm formation by blocking the catalytic activity of these enzymes or downregulating their genetic expression.

Other names
GtfBGtfCGTF-IGTF-SIGlucosyltransferase-IGlucosyltransferase-SIStreptococcus mutans glucosyltransferases
02

Mechanism of action

Inhibition of enzymatic activity by binding to the catalytic site (competitive inhibition) or the glucan-binding domains (non-competitive inhibition), or downregulation of gene expression via the VicRK two-component system (Bowen and Koo, 2011; Ren et al., 2015).

03

Biological functions

Biofilm formationExtracellular polysaccharide (EPS) synthesisBacterial adhesionSucrose metabolism
04

Disease associations

InfectionDental cariesInfective endocarditis
05

Safety considerations

Potential disruption of commensal oral microbiota (Zhang et al., 2021)Reduced efficacy against surface-adsorbed enzymes compared to soluble forms (Bowen and Koo, 2011)Challenges in maintaining therapeutic concentrations in the oral cavity due to salivary clearance
06

Interacting drugs

Acarbose

7 more in the full profile.

07

Biomarkers

Extracellular polysaccharide (EPS) concentration in dental plaque (Bowen and Koo, 2011)Streptococcus mutans biofilm density (Zhang et al., 2021)Ratio of water-insoluble to water-soluble glucans (Koo et al., 2010)

Beyond the preview

Go deeper on Glucosyltransferase B (GtfB) and Glucosyltransferase C (GtfC) of Streptococcus mutans (GtfB and GtfC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucosyltransferase B (GtfB) and Glucosyltransferase C (GtfC) of Streptococcus mutans (GtfB and GtfC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call